<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30166274</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Print">1929-0748</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>7</Volume>                    <Issue>8</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>JMIR research protocols</Title>                <ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation>            </Journal>            <ArticleTitle>A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial.</ArticleTitle>            <Pagination>                <MedlinePgn>e10487</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2196/10487</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">About 5% of breast cancer cases are metastatic at diagnosis, and 20%-30% of localized breast cancer cases become secondarily metastatic. Patients frequently report many detrimental symptoms related to metastasis and treatments. The physical, biological, psychological, and clinical benefits of physical activity during treatment in patients with localized breast cancer have been demonstrated; however, limited literature exists regarding physical activity and physical activity behavior change in patients with metastatic breast cancer.</AbstractText>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The primary objective of this study is to assess the feasibility of a 6-month physical activity intervention with activity trackers in patients with metastatic breast cancer (the Advanced stage Breast cancer and Lifestyle Exercise, ABLE Trial). Secondary objectives are to examine the effects of physical activity on physical, psychological, anthropometrics, clinical, and biological parameters.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We plan to conduct a single-center, single-arm trial with 60 patients who are newly diagnosed with metastatic breast cancer. Patients will receive an unsupervised and personalized 6-month physical activity program that includes an activity tracker Nokia Go and is based on the physical activity recommendation. Patients will be encouraged to accumulate at least 150 minutes per week of moderate-to-vigorous intensity physical activity. Baseline and 6-month assessments will include anthropometric measures, functional tests (eg, 6-minute walk test and upper and lower limb strength), blood draws, patient-reported surveys (eg, quality of life and fatigue), and clinical markers of tumor progression (eg, Response Evaluation Criteria In Solid Tumors criteria).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Data collection occurred between October 2016 and January 2018, and the results are expected in August 2018.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The ABLE Trial will be the first study to assess the feasibility and effectiveness of an unsupervised and personalized physical activity intervention performed under real-life conditions with activity trackers in patients with metastatic breast cancer.</AbstractText>                <AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT03148886; https://clinicaltrials.gov/ct2/show/NCT03148886 (Accessed by WebCite at http://www.webcitation.org/71yabi0la).</AbstractText>                <AbstractText Label="REGISTERED REPORT IDENTIFIER" NlmCategory="UNASSIGNED">RR1-10.2196/10487.</AbstractText>                <CopyrightInformation>©Lidia Delrieu, Olivia Pérol, Béatrice Fervers, Christine Friedenreich, Jeff Vallance, Olivia Febvey-Combes, David Pérol, Brice Canada, Eva Roitmann, Armelle Dufresne, Thomas Bachelot, Pierre-Etienne Heudel, Olivier Trédan, Marina Touillaud, Vincent Pialoux. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 30.08.2018.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y" EqualContrib="Y">                    <LastName>Delrieu</LastName>                    <ForeName>Lidia</ForeName>                    <Initials>L</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1240-5390</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Cancer and Environment, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Inter-University Laboratory of Human Movement Biology, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pérol</LastName>                    <ForeName>Olivia</ForeName>                    <Initials>O</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7543-7050</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Cancer and Environment, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fervers</LastName>                    <ForeName>Béatrice</ForeName>                    <Initials>B</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3498-6499</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Cancer and Environment, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Inserm U1052, Cancer Research Center of Lyon, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Friedenreich</LastName>                    <ForeName>Christine</ForeName>                    <Initials>C</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4783-1966</Identifier>                    <AffiliationInfo>                        <Affiliation>Alberta Health Services, Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vallance</LastName>                    <ForeName>Jeff</ForeName>                    <Initials>J</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4923-9886</Identifier>                    <AffiliationInfo>                        <Affiliation>Faculty of Health Disciplines, Athabasca University, Athabasca, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Febvey-Combes</LastName>                    <ForeName>Olivia</ForeName>                    <Initials>O</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4888-0815</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pérol</LastName>                    <ForeName>David</ForeName>                    <Initials>D</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6429-7419</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Canada</LastName>                    <ForeName>Brice</ForeName>                    <Initials>B</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2098-433X</Identifier>                    <AffiliationInfo>                        <Affiliation>Laboratory on Vulnerabilities and Innovations in Sport, University Claude Bernard Lyon 1, University of Lyon, Villeurbanne, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Roitmann</LastName>                    <ForeName>Eva</ForeName>                    <Initials>E</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8279-8017</Identifier>                    <AffiliationInfo>                        <Affiliation>Digital Health, Data and Studies Department, Nokia Technologies, Issy-Les-Moulineaux, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dufresne</LastName>                    <ForeName>Armelle</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6637-3526</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bachelot</LastName>                    <ForeName>Thomas</ForeName>                    <Initials>T</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0866-9484</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Heudel</LastName>                    <ForeName>Pierre-Etienne</ForeName>                    <Initials>PE</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8555-8921</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Trédan</LastName>                    <ForeName>Olivier</ForeName>                    <Initials>O</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5881-9383</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Touillaud</LastName>                    <ForeName>Marina</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9900-5861</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Cancer and Environment, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Inserm U1052, Cancer Research Center of Lyon, Léon Bérard Cancer Center, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pialoux</LastName>                    <ForeName>Vincent</ForeName>                    <Initials>V</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2057-061X</Identifier>                    <AffiliationInfo>                        <Affiliation>Inter-University Laboratory of Human Movement Biology, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Institut Universitaire de France, Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <DataBankList CompleteYN="Y">                <DataBank>                    <DataBankName>ClinicalTrials.gov</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>NCT03148886</AccessionNumber>                    </AccessionNumberList>                </DataBank>            </DataBankList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Canada</Country>            <MedlineTA>JMIR Res Protoc</MedlineTA>            <NlmUniqueID>101599504</NlmUniqueID>            <ISSNLinking>1929-0748</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Indian J Cancer. 2009 Apr-Jun;46(2):146-50</RefSource>                <PMID Version="1">19346649</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2017 Feb;161(3):443-452</RefSource>                <PMID Version="1">27933450</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Mar 19;10(3):e0118723</RefSource>                <PMID Version="1">25789630</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Aging Phys Act. 2016 Oct;24(4):508-515</RefSource>                <PMID Version="1">26796231</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ Open Sport Exerc Med. 2016 Oct 24;2(1):e000171</RefSource>                <PMID Version="1">27900199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Public Health. 2015 Aug;25(4):604-9</RefSource>                <PMID Version="1">25624273</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Prev Med. 2015 Sep;49(3):414-8</RefSource>                <PMID Version="1">26071863</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1995 May;13(5):1249-54</RefSource>                <PMID Version="1">7738629</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Essays Biochem. 2006;42:105-17</RefSource>                <PMID Version="1">17144883</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Jan;149(2):331-42</RefSource>                <PMID Version="1">25555831</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Internet Res. 2014 Aug 15;16(8):e192</RefSource>                <PMID Version="1">25131661</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Public Health. 2017 Jan 11;4:289</RefSource>                <PMID Version="1">28123997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Behav Med. 2013 Dec;20(4):522-8</RefSource>                <PMID Version="1">22992864</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Nurs Forum. 2004 Sep 17;31(5):977-83</RefSource>                <PMID Version="1">15378098</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Behav Med. 2014 Aug;37(4):595-606</RefSource>                <PMID Version="1">23943140</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Nurs Forum. 1998 May;25(4):677-84</RefSource>                <PMID Version="1">9599351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2016 Apr 15;122(8):1169-77</RefSource>                <PMID Version="1">26872302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JMIR Mhealth Uhealth. 2016 Jan 27;4(1):e7</RefSource>                <PMID Version="1">26818775</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Physiol Regul Integr Comp Physiol. 2017 Mar 1;312(3):R358-R367</RefSource>                <PMID Version="1">28052867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2016 Aug 25;16(1):682</RefSource>                <PMID Version="1">27562357</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Immunother. 2017 May;66(5):667-671</RefSource>                <PMID Version="1">28324125</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2012 Jul 10;30(20):2530-7</RefSource>                <PMID Version="1">22614980</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2014 Jun;22(6):1537-48</RefSource>                <PMID Version="1">24424484</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2001;3(5):323-7</RefSource>                <PMID Version="1">11597322</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Sports Sci Med Rehabil. 2015 Oct 12;7:24</RefSource>                <PMID Version="1">26464801</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Sci Sports Exerc. 2011 Aug;43(8):1575-81</RefSource>                <PMID Version="1">21681120</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2018 Jun 15;124(12):2552-2560</RefSource>                <PMID Version="1">29624641</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Oncol (R Coll Radiol). 2010 Apr;22(3):208-21</RefSource>                <PMID Version="1">20110159</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2009 Jan;45(2):228-47</RefSource>                <PMID Version="1">19097774</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2014 May;21(3):262-74</RefSource>                <PMID Version="1">24569944</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Sports Med. 2013 Jul;34(7):631-6</RefSource>                <PMID Version="1">23444095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2009 Nov;20(11):1771-85</RefSource>                <PMID Version="1">19608616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Manipulative Physiol Ther. 2014 Mar-Apr;37(3):206-10</RefSource>                <PMID Version="1">24630769</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Appl Physiol Occup Physiol. 1987;56(6):679-85</RefSource>                <PMID Version="1">3678222</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cardiovasc Res. 2005 Aug 1;67(2):187-97</RefSource>                <PMID Version="1">15935334</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2011;16(11):1649-57</RefSource>                <PMID Version="1">21948693</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2015 May;54(5):635-54</RefSource>                <PMID Version="1">25752971</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Phys Act Health. 2011 Aug;8(6):858-65</RefSource>                <PMID Version="1">21832302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sports Med. 2004;34(1):1-8</RefSource>                <PMID Version="1">14715035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Auckl). 2016 Jul 14;10:93-102</RefSource>                <PMID Version="1">27441001</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):355-365</RefSource>                <PMID Version="1">27742668</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Physiol (Oxf). 2012 Aug;205(4):541-50</RefSource>                <PMID Version="1">22409225</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2001 Sep 15;92(6 Suppl):1689-93</RefSource>                <PMID Version="1">11598888</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Physiol. 2017 Feb 13;8:84</RefSource>                <PMID Version="1">28243207</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2004 Aug 15;22(16):3302-8</RefSource>                <PMID Version="1">15310773</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Surviv. 2010 Jun;4(2):87-100</RefSource>                <PMID Version="1">20052559</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Rech Soins Infirm. 2002 Mar;(68):50-65</RefSource>                <PMID Version="1">12001628</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2003 Apr;3(4):276-85</RefSource>                <PMID Version="1">12671666</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncology (Williston Park). 2015 Dec;29(12):908-20, 922</RefSource>                <PMID Version="1">26676894</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">activity trackers</Keyword>            <Keyword MajorTopicYN="N">feasibility</Keyword>            <Keyword MajorTopicYN="N">metastatic breast cancer</Keyword>            <Keyword MajorTopicYN="N">oxidative stress</Keyword>            <Keyword MajorTopicYN="N">physical activity</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30166274</ArticleId>            <ArticleId IdType="pii">v7i8e10487</ArticleId>            <ArticleId IdType="doi">10.2196/10487</ArticleId>            <ArticleId IdType="pmc">PMC6137283</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>